EB1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitro.
about
Preadministration of High-Dose Salicylates, Suppressors of NF- B Activation, May Increase the Chemosensitivity of Many Cancers: An Example of Proapoptotic Signal Modulation Therapy1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue.Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian populationAnti-oestrogen resistant human breast cancer cell lines are more sensitive towards treatment with the vitamin D analogue EB1089 than parent MCF-7 cellsDifferential regulation of survivin expression and apoptosis by vitamin D3 compounds in two isogenic MCF-7 breast cancer cell sublinesGenomic vitamin D signaling in breast cancer: Insights from animal models and human cells.Recent developments in the use of vitamin D analogues.(Patho)physiological implications of the novel epithelial Ca2+ channels TRPV5 and TRPV6.Cellular and molecular effects of vitamin D on carcinogenesis.The human cytomegalovirus lytic cycle is induced by 1,25-dihydroxyvitamin D3 in peripheral blood monocytes and in the THP-1 monocytic cell lineRole of vitamin D in uterine fibroid biologyEquivalent anticancer activities of dietary vitamin D and calcitriol in an animal model of breast cancer: importance of mammary CYP27B1 for treatment and prevention.Comparative regulation of gene expression by 1,25-dihydroxyvitamin D3 in cells derived from normal mammary tissue and breast cancerA phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancer.A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinomaEvaluation of the potential therapeutic role of a new generation of vitamin D analog, MART-10, in human pancreatic cancer cells in vitro and in vivo.Mechanism of UV-related carcinogenesis and its contribution to nevi/melanomaThe sum of many small changes: microRNAs are specifically and potentially globally altered by vitamin D3 metabolites.A xenograft animal model of human arteriovenous malformations.The future of vitamin D analogs.1alpha,25-dihydroxyvitamin D(3) (calcitriol) and its analogue, 19-nor-1alpha,25(OH)(2)D(2), potentiate the effects of ionising radiation on human prostate cancer cells.22-Oxa-1alpha,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer.Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells.Differential and antagonistic effects of 9-cis-retinoic acid and vitamin D analogues on pancreatic cancer cells in vitroIdentification of novel mediators of Vitamin D signaling and 1,25(OH)2D3 resistance in mammary cells.22-oxa-1,25-dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculture of cholangiocarcinoma.
P2860
Q22299231-B3D8BEAC-2EA5-4074-8F23-32C3AFD5ABDDQ24632275-1CB2962A-1E44-45AF-9A8E-B3A38ACD2946Q25257771-3D151385-28F4-4DE0-AD00-EC7273E83567Q28344334-E9D6A4AC-B0B5-440A-8F49-C715B8CFB986Q28359567-105B0019-34BD-46F0-8D4A-83AEB3181D82Q33646953-F45EE704-E864-4738-AE27-EF6572E127E8Q34005554-B1E95744-6ACB-4C7C-A0FB-15D23CB81121Q34074734-1E445040-D393-4571-88F0-F382C9874D7CQ35128277-547D0606-964C-4558-959D-411DFC64135DQ35809633-E7C08832-BEA0-42EE-9C6A-7DF370A87615Q35893959-B171E488-6E96-42FC-8B30-C78FC2CB59EBQ36030956-6326CAD4-DB54-42A6-B539-C7DDAD97CAF5Q36561789-AF30082D-7311-4AD0-8C7D-08E1671E83B8Q36596915-4D8C9D13-7D77-42B8-A049-A0B8006F805AQ36644189-C52B74F3-4A9E-4CE6-ACFD-5935193E3CA3Q36670965-35B1C349-369D-45EF-8886-9A9E3488744CQ36906268-EBA7C1E1-CF28-469C-9EC0-F34AA0567064Q36930745-43C63A7B-ECAA-4F5E-8369-B755EAFFA84BQ36941178-34FF69F4-4BB3-4CE3-81DD-8C32E5802978Q37428380-5FCE49AB-F2FE-47DB-BD72-E53769B9CC34Q37695300-8C2D5F43-C539-4FCD-A129-39DE69AE989BQ38305355-03648A81-0953-4BFF-9485-14B92975C927Q40457024-030FB3FD-FBB5-422A-AB78-98182CF46A9AQ40789892-D5088008-D5D9-420E-85BE-27021A7DC355Q41823940-E9522EA1-CC4F-4339-A6D9-3CCDC316AA82Q42098474-FFCBAD5E-FD7A-46BA-BBDB-6306BB80A4D3Q42948495-66F7FD18-6ECB-4888-B6AB-F375380E77F1
P2860
EB1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitro.
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
name
EB1089, a synthetic analogue o ...... er cells in vivo and in vitro.
@ast
EB1089, a synthetic analogue o ...... er cells in vivo and in vitro.
@en
type
label
EB1089, a synthetic analogue o ...... er cells in vivo and in vitro.
@ast
EB1089, a synthetic analogue o ...... er cells in vivo and in vitro.
@en
prefLabel
EB1089, a synthetic analogue o ...... er cells in vivo and in vitro.
@ast
EB1089, a synthetic analogue o ...... er cells in vivo and in vitro.
@en
P2093
P356
P1476
EB1089, a synthetic analogue o ...... er cells in vivo and in vitro.
@en
P2093
P2860
P304
P356
10.1038/SJ.BJP.0702103
P407
P577
1998-11-01T00:00:00Z